Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Redox cycling between copper(I) (Cu⁺) and copper(II) (Cu²⁺) refers to the reversible interconversion of these two oxidation states of copper. This process is fundamental in both biological systems and synthetic chemistry due to its role in electron transfer reactions, catalysis, and reactive oxygen species (ROS) generation. The cycling is highly dependent on the ligand environment and plays essential roles in enzymatic activity related to energy metabolism and defense against oxidative damage. Synthetic analogs are used extensively for studying mechanisms relevant to biology as well as developing new catalysts.
Redox cycling mediates chemical transformations, including oxidation-reduction reactions and ROS generation via Fenton-like reactions.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Redox Cycling Between Copper(I) and Copper(II) (Cu(I)/Cu(II) Redox Cycling).